Acquired resistance to BRAF V600E inhibitors remains a major obstacle in melanoma treatment. We hypothesized that melano...
Current molecular classification model for thyroid cancer (TC), which relies on BRAF-RAS score genes has limited efficac...
...brafenib, a BRAF inhibitor, for wound healing applications using the chick embryo Chorioallantoic Membrane (CAM) assay. ...
...BRAF V600E-mutated lung adenocarcinoma. [¹⁸F]FES PET/CT proved crucial in differentiating synchronous primary malignanci...
...BRAF-V600E (n = 19) and control-arm patients with either TMB and BRAF status combination (n = 31). With TMB ≥9 or BRAF-V...
...BRAF or KRAS mutation, but premalignant KRAS-mutant sessile serrated lesions are rare. Here, we model Kras- and Braf-mut...
...BRAF c.1574 T > C variants, neither previously reported in ASC. TC717 provides a valuable preclinical platform for inves...
...BRAF, KRAS, or NRAS mutations were detected; mismatch repair protein expression was intact. Genetic counseling identifie...
...BRAF) wild-type metastatic colorectal cancer. In this post-hoc biomarker analysis, plasma samples were collected at base...
...BRAF, NRAS, KIT, TERT, NF1, CDKN2A), immune (PD-L1, LAG-3, TIGIT, TILs, TMB), proteomic (S100B, MMPs, signaling signatur...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269